background. Controversy remains about the longevity of correction in autologous fat grafts and its relation to adipocyte survival. Reported long-term fat graft survival rates differ widely, depending on harvesting method, means of reinjection, injection site, and evaluation methods. 
THE HISTORY OF autologous fat transplantation begins in Europe. The first communication about fat transplantation was presented by Neuber 1 to the 22nd Congress of the German Surgical Society in 1893, followed by Czerny, 2 Lexer, 3 and Rehn. 4 Transplanted fat was used for a variety of surgical procedures, including thoracic surgery, 5 abdominal surgery, 6 neurosurgery, 7 orthopedic surgery, 8 and breast surgery. 9, 10 In 1911, Bruning 11 was the first to inject autologous fat into the subcutaneous tissue for the purpose of soft tissue augmentation.
With the advent of liposuction surgery the harvesting process became an easy outpatient procedure. In the 1980s, Illouz 12, 13 and Fournier 14 developed an easy approach to fat transfer by syringe harvesting, called "microlipoinjection" by Fournier. 15 Today there are different well-described techniques for fat transfer, although a standard procedure that is adopted by all practitioners has not yet been developed.
Longevity as well as actual survival of the semiliquid fat graft is still a matter of controversy. Specifically the following questions need to be addressed: the survival of fat cells after harvesting, the role of anesthesia of the donor site, the role of the cannula or needle used in harvesting and reinjection, the role of blood in transplanted fat, trauma during cleaning process, exposure to air, contamination of graft, histologic fate of reinjected fat, durability of the correction, and the relation between longevity of augmentation and fat cell survival.
Studies are difficult to compare, as different authors use different harvesting techniques, reinjection techniques, and means of evaluating the outcome. In Table  1 , an attempt is made to give an overview of the current state of findings in regard to the above mentioned questions.
Anesthesia of the Donor Site
Although many authors consider local anesthesia to have a counterproductive effect, [16] [17] [18] [19] [20] [21] review of the literature shows similar survival rates for aspirated fat, whether or not local anesthesia is applied. While it is argued that reduced blood supply by local application of epinephrine is going to have a harmful effect on the graft, this view cannot be supported by clinical evidence from any study. On the contrary, vasoconstriction before extraction will help tissue to maintain viability through reduced bleeding. Tissue necrosis by local application of epinephrine is not a side effect of any simple excision and patients being operated on in tumescent technique are not left behind with dead adipocytes after liposuction surgery. Moore et al. 22 have shown that lidocaine potently inhibits glucose transport and lipolysis in adipocytes and their growth in culture; that effect, however, persisted only as long as lidocaine was present. After washing the cells were able to fully regain their function and growth regard- 22 In vivo exposure to lidocaine has no effect at all, so that harvesting under local anesthesia can be done to obtain subcutaneous fat for metabolic studies. 22 Finally, it has been clearly demonstrated that amide local anesthetics enhance wound healing by reducing leukocyte migration, reducing local metabolic activation of leukocytes, and reducing release of toxic substances such as oxygen free radicals and lysozymes known to impair wound healing. 23, 24 
Lipoextraction and Survival of Fat Cells After Harvesting
Fat harvesting by liposuction does not result in increased fat cell damage compared to fat harvesting by excision. This was shown in a recent study using a glycerol-3-phosphate dehydrogenase (G3PDH) enzyme assay to compare the viability of adipocytes harvested by both methods. 25 Leakage of this lipogenic enzyme G3PDH through the plasma membrane would be a potential indicator of fat cell damage. Schuller-Petrovic 26 demonstrated only a few dead cells by trypan blue staining even after defrosting (see also Figure 1 ). The opinion of many surgeons that fat grafting does not work because the fat cells do not survive transfer has to be changed in the light of these new findings.
No correlation can be found between survival of fat harvested with syringe or machine aspiration (see Table 1) . A syringe produces a relative vacuum of about Ϫ 0.6 atm. Only if maximum negative pressure of Ϫ 0.95 atm in machine aspiration is applied may partial breakage and vaporization of fatty tissue occur.
The diameter of the fat cells is mechanically distended and is larger than in lipocytes extracted at Ϫ 0.5 atm. 27 No correlation can be found between survival of fat harvested with a liposuction cannula or 14-gauge needle (see Table 1 ). Isolated adipocytes remain highly viable after harvesting with a 3 mm liposuction cannula, as evidenced by glucose transport assays, and may even be used for metabolic studies in adipose patients. 28 Sudan black staining, which may be used to demonstrate viable fat cells, showed an average of 14.000 and 15.28 live fat cells in 1 mm 3 for cannula and syringe harvesting, respectively, in a study conducted by Novaes et al. 20 
Blood in Transplanted Fat
All authors agree that blood in transplanted fat accelerates degradation of transplanted fat.
Trauma During the Cleaning Process
Fat cells do not seem to be as fragile as many surgeons believe. As shown above, they survive almost any harvesting method. The results in Table 1 do not point to any difference in outcome, whether there was centrifugation, vigorous washing, or no washing at all.
Exposure to Air, Contamination of the Graft
Most authors favor a closed technique. Advantages are maintenance of sterility and avoiding exposure to air. Fat should not be allowed to dry out completely as this would destroy adipocytes. The open technique, however, provides the surgeon with the opportunity to separate bigger fibers from the tissue and produce a graft that is easier to inject. 29 Exposure to air carries the risk of contamination. Although no published data are available yet, clinical experience shows that this risk is no greater than with the closed technique, where infection is very rare. 30 
Freezing of Adipocytes
Slow freezing of the tissue to Ϫ 20 Њ C shortly after harvesting has no harmful effect on the adipocytes. Studies show that there are a high number of viable cells even after defrosting. 26 Figure 1 shows one dead adipocyte on trypan blue staining among some living fat cells and a background of fatty microdroplets. Trypan blue staining is a negative staining method used to demonstrate live cells; the staining color penetrates defective cell walls. This cytologic picture was taken from machine-assisted aspiration of abdominal fat with a 3 mm blunt liposuction cannula after defrosting (3 years at Ϫ 20 Њ C) and manipulation through a luer-to-luer adapter and a 24-gauge needle. It clearly demonstrates the sturdiness of aspirated adipocytes. A storing period of up to 6 months is recommended, 30 although we sometimes store longer than this. Slow freezing to Ϫ 20 Њ C is preferable if one wants to transplant viable adipocytes, whereas flash freezing may be used to destroy adipocytes, as in lipocytic dermal augmentation. 31 
Liporeinjection
Most authors use 14-to 25-gauge needles for reinjection, depending on harvesting and processing technique. There seems to be no correlation between the diameter of the needle and longevity of correction.
Histologic Fate of Reinjected Fat
There are few reports on the histologic fate of reinjected fat in humans. Schuller-Petrovic 26 found living fat cells, some collapsed, at 2 weeks after injection. Carpaneda 32 studied collagen alterations in adipose tissue autografts to the abdominal subcutaneous fat in patients prior to abdominoplasty. The grafting intervals were 60, 30, 21, 15, 12, 8, and 5 days prior to the abdominoplasty. He found a type I collagen capsule circumscribing the graft, besides several alterations in the synthesis, degradation, and remodeling of type I and type III collagen within the transplanted tissue. An increase and decrease of inflammatory response in a time sequence was shown as well as a shift in the inflammatory process from the peripheral viable region to the central inviable region, where small pseudocysts and nonnucleated adipocytes were present.
Coleman 31 transplanted mechanically disrupted adipocytes and found rounded vacuoles 1 week after the transplantation at the injection site and, obviously, no intact adipocytes. At 1 month, perivascular spaces widened and contained sparse lymphocytic infiltrates, a new zone of connective tissue between the reticular dermis, and the subcutaneous fat developed.
All reports with a systematic research layout are conducted on animal models. Guerrerosantos et al. 16 found that fat transplants into subcutaneous tissue were impossible to identify or separate from the already existent fat. In his study on 120 Wistar rats, only part of the fat implanted into subcutaneous tissue seemed to survive, while fat strips implanted intramuscularly not only survived well, but showed some augmentation in size in relation to the initial size of the graft.
Blood Supply at the Recipient Site
Although some authors assume that fat cells survive best in muscular tissue because of the high vascularity, 16 clinical evidence shows good survival in hemiatrophia hemifacialis and posttraumatic scars despite decreased vascularity in these conditions. 26 
Durability of the Correction
The durability of the achieved correction remains somewhat unpredictable despite all efforts to improve techniques. The longest durability can be expected in atrophies after scleroderma (hemiatrophy, saber-cut type), postsurgical or traumatic atrophy, and depressed scars. 26 For aging changes, the results are initially excellent but show a higher rate of loss of volume so that touch-up procedures may be necessary. There are welldocumented cases where autologous fat transplantation lasted 8 years and more. 26, 33 
Findings in Nondermatologic Fat Transfer
The fate of injected fat has been studied in a variety of nondermatologic diseases. When used for perianal submucosal injection to treat sphincteric incontinence, Shafik 34 found 3 of 14 patients maintained sufficient volume at 18-month follow-up, 7 of 14 required one touchup injection, and 4 of 14 required two touch-up injections. Survival of fat used for frontal sinus obliteration did not yield satisfactory results, with fat necrosis being present in 5 of 8 cases 6-24 months postoperatively. 35 The average volumetric "take" following injections of the canine vocal fold was about 20% at 12 weeks in a study conducted by Mikus et al. 36 Of interest, liposuctioned fat was significantly superior to grafts prepared by the purification method. Chairman 37 adapted the cosmetic procedure of fat transfer to a therapeutic procedure for the foot. Treating 50 patients for restoration of the plantar fat pad, he found an increased fat pad in 48 patients, 1 patient required an additional transfer 6 months after surgery. At 5 years follow-up after fat autotransplantation for first web space atrophy following posttraumatic ulnar nerve palsies, 21 of 25 patients had slight loss of volume, whereas 4 of 21 retained the initial overcorrection. 38 There are reports that pacemaker pocket neuralgia secondary to inadequate subcutaneous tissue between the pacemaker and overlying skin may now be treated by lipoinjection. 39 
Discussion
In 1988 Glogau 40 put forward the following questions: What is the documented fate of the fat graft? How much survives the initial transfer? How much survives long-term? In this article an attempt is made to give an overview of the preliminary answers the scientific community has to give. Some questions have been addressed, others still await definitive solutions.
There are two approaches to soft tissue augmentation: use of permanent or resorbable fillers. Whenever permanent fillers such as polytetrafluoroethylene (PTFE) or polymethylmethacrylate (PMMA) are used, the possibility or impossibility of extraction of unwanted material has to be kept in mind. Whereas single implants such as PTFE can be removed, silicon oil, Artecoll, and Dermalive are distributed diffusely into the subcutaneous tissue. The difficulty or impossibility of removing millions of 30 m implants such as PMMA-spheres in the event of an undesired immune response to the material should be discussed with the patient. 41 No human face is "permanent." As skin atrophy progresses in the aging individual, permanent implants are more likely to be detected through the thinned skin. We refer to this phenomenon as the "snow-melting effect": after the snow has largely disappeared in the spring, the snow surface now follows every stone surface instead of lying perfectly straight (Reinmüller R, pers. comm.).
By far the most popular substance currently used for soft tissue augmentation is injectable bovine collagen. 42, 43 The duration of the correction from injectable collagen depends on the underlying cause and location of the implant and varies between 6 and 24 months. 44, 45 Autologous fat has to be regarded as a nonpermanent implant. Compared to other nonpermanent filler substances, the longevity is equal but not as easily predictable. Under unfavorable conditions most of the graft can be lost after 4 weeks, while in other cases the correction lasted up to 7 years, with histologic evidence of living adipocytes (Figure 2 ).
While it has been shown that fat augmentation, on average, has more staying power than injectable collagen, 18 some authors consider loss of volume over a period of 3 years disappointing. 46 Is the glass half full or half empty? Is an average maintenance of correction of 6 months good or unsatisfactory? We have to determine our goals in augmentation therapy.
Authors writing on fat transfer share the view that fatty tissue has a delicate structure that is easily damaged by mechanical insults. Neither our own experiences nor the evidence from the literature seems to support this view. Even if aspirated fat that was stored for 3 years at Ϫ20ЊC is manipulated multiple times through luer-to-luer adapter, many living cells can be found by trypan blue staining (Figure 1 ). The majority of mechanically aspirated fat cells are viable, as was shown by biochemical assay studies. 25 It may be confusing if surgeons argue about adipocyte viability after lipoextraction when at the same time they flash freeze the transplant in liquid nitrogen. 47 The principle of flash freezing is used in cryotherapy for skin cancer and works by destroying cells through the formation of ice crystals, dehydration, and toxic electrolyte concentrations. 48 When storing spermatozoa for further use, the freezing is a complex process that involves multiple temperature steps in order to protect the living cells.
Do we want to transplant living fat cells or fat microdroplets? It is evident that reinjected cell debris such as fat droplets will be resorbed by the host tissue in a relatively short time, whereas living cells will persist longer or even permanently (Figure 2 ).
There is some disagreement as to the role of fibrosis. While some authors think that fibroblasts can only cause contraction, 49 it is certainly true that they can provide augmentation as well; a good example is benign fibrous histiocytoma. On the other hand, some believe that the fibrous host reaction may be all that occurs in some patients. 50 Passot in 1920 stated that it does not matter what ultimately happens to the transplanted fat as long as it fulfills its goal of filling a space (51, cited by 52).
Conclusion
Longevity of correction after fat transfer depends on the tissue, mobility, and the vascularity of the anatomic recipient site. Fat cells are relatively sturdy and do survive syringe and medium-power vacuum pump aspiration equally well. The use of lipoaspiration cannulas is as effective as a 14-gauge needle for lipoextraction. Concerning technique, it seems to be important that only small amounts of fat are transferred and emphasis is placed on careful distribution into the recipient tissues. 
